Literature DB >> 6356131

Differential agglutination by soybean agglutinin of human leukemia and neuroblastoma cell lines: potential application to autologous bone marrow transplantation.

Y Reisner.   

Abstract

Normal human bone marrow cells were mixed with radioactively labeled tumor cells from different leukemia and neuroblastoma cell lines, and the cell mixtures were separated by differential agglutination with soybean agglutinin. It is shown that the cell fraction unagglutinated by soybean agglutinin, which was previously found to be capable of reconstituting the hematopoietic system of lethally irradiated recipients, can be purged of tumor cells with varying efficiency depending on the tumor cell expression of soybean agglutinin receptors as detected by flow cytofluorimetry with fluoresceinated soybean agglutinin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356131      PMCID: PMC391229          DOI: 10.1073/pnas.80.21.6657

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.

Authors:  Y Reisner; L Itzicovitch; A Meshorer; N Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Transformation of neuraminidase-treated lymphocytes by soybean agglutinin.

Authors:  A Novogrodsky; E Katchalski
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

5.  Cytolytic effect of 6-hydroxydopamine on neuroblastoma cells.

Authors:  P U Angeletti; R Levi-Montalcini
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

6.  Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin.

Authors:  Y Reisner; N Kapoor; R J O'Reilly; R A Good
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

7.  Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

Authors:  K A Krolick; C Villemez; P Isakson; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; B Dupont; R A Good; R J O'Reilly
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

9.  Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide.

Authors:  S J Sharkis; G W Santos; M Colvin
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

10.  Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin.

Authors:  Y Reisner; N Kapoor; M Z Hodes; R J O'Reilly; R A Good
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

View more
  6 in total

1.  The use of lectins to study normal differentiation and malignant transformation.

Authors:  A Raedler; E Raedler
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.

Authors:  A Nagler; S Morecki; S Slavin
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

Review 3.  Use of lectins in immunohematology.

Authors:  Ajit C Gorakshakar; Kanjaksha Ghosh
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

Review 4.  Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options.

Authors:  Suk See De Ravin; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

5.  Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.

Authors:  J T Kemshead; L Heath; F M Gibson; F Katz; F Richmond; J Treleaven; J Ugelstad
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

6.  Purification of melibiose-binding lectins from two cultivars of Chinese black soybeans.

Authors:  Peng Lin; Xiujuan Ye; Tb Ng
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-12       Impact factor: 3.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.